BAM
MDNA

Belpointe Asset Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Belpointe Asset Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,249
Closed -$6.45K – 3640
2023
Q1 		$6.45K Hold
10,249
– – ﹤0.01% 2914
2022
Q4 		$4.69K Buy
+10,249
New +$4.69K ﹤0.01% 2956